Oxelumab
Oxelumab
Oxelumab (pronunciation: ox-eh-loo-mab) is a monoclonal antibody designed for the treatment of various autoimmune diseases and cancers.
Etymology
The name "Oxelumab" is derived from the standard nomenclature for monoclonal antibodies. The suffix "-mab" stands for "monoclonal antibody", while the prefix "Oxelu-" does not have a specific meaning and is used for unique identification.
Function
Oxelumab works by binding to specific proteins or cells, blocking their activity and thereby preventing the progression of the disease. It is part of a larger class of drugs known as biologics, which are derived from living organisms and used in the treatment of various medical conditions.
Related Terms
- Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Autoimmune Disease: A condition in which your immune system mistakenly attacks your body.
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
- Biologics: A type of medication that is made from living organisms and used to treat conditions like autoimmune diseases and cancer.
Usage
Oxelumab is administered through intravenous infusion, usually in a hospital or clinic. The dosage and frequency of administration depend on the specific condition being treated and the patient's overall health status.
Side Effects
Like all medications, Oxelumab can cause side effects. These may include nausea, fatigue, and fever. In rare cases, serious side effects such as allergic reactions or infections may occur.
External links
- Medical encyclopedia article on Oxelumab
- Wikipedia's article - Oxelumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski